190 related articles for article (PubMed ID: 19705642)
1. European Union directives and their effect on the registration and authorisation of anthroposophic and homeopathic medicines.
Laso LR; Alfonso-Galán MT
Med Law; 2009 Mar; 28(2):269-82. PubMed ID: 19705642
[TBL] [Abstract][Full Text] [Related]
2. Should Anthroposophic Medicinal Products Be Regulated in Europe?
Michaux G
Eur J Health Law; 2017 Mar; 24(1):46-66. PubMed ID: 29210253
[TBL] [Abstract][Full Text] [Related]
3. Possible dangers for patients using homeopathy: may a homeopathic medicinal product contain active substances that are not homeopathic dilutions?
Cuesta Laso LR; Alfonso Galán MT
Med Law; 2007 Jun; 26(2):375-86. PubMed ID: 17639858
[TBL] [Abstract][Full Text] [Related]
4. Viral safety in homoeopathic medicinal products.
Schultz N; Franck-Karl G; Schilk J; Rose N
Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):55-65. PubMed ID: 21619856
[TBL] [Abstract][Full Text] [Related]
5. Adverse drug reactions to anthroposophic and homeopathic solutions for injection: a systematic evaluation of German pharmacovigilance databases.
Jong MC; Jong MU; Baars EW
Pharmacoepidemiol Drug Saf; 2012 Dec; 21(12):1295-301. PubMed ID: 22692862
[TBL] [Abstract][Full Text] [Related]
6. The legal framework governing the quality of (traditional) herbal medicinal products in the European Union.
Kroes BH
J Ethnopharmacol; 2014 Dec; 158 Pt B():449-53. PubMed ID: 25086408
[TBL] [Abstract][Full Text] [Related]
7. Thoughts, beliefs and concepts concerning infectious childhood diseases of physicians practicing homeopathic, anthroposophic and conventional medicine - a qualitative study.
Mittring-Junghans N; Holmberg C; Witt CM; Teut M
BMC Complement Med Ther; 2021 Jan; 21(1):46. PubMed ID: 33499846
[TBL] [Abstract][Full Text] [Related]
8. [The regulatory framework for complementary and alternative medicines in Europe].
Knöss W; Stolte F; Reh K
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jul; 51(7):771-8. PubMed ID: 18584103
[TBL] [Abstract][Full Text] [Related]
9. [Special therapeutic guidelines from the viewpoint of BfArM (Federal Institute for Drug and Medical Products)].
Keller K
Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):669-74. PubMed ID: 9527466
[TBL] [Abstract][Full Text] [Related]
10. Current concepts on integrative safety assessment of active substances of botanical, mineral or chemical origin in homeopathic medicinal products within the European regulatory framework.
Buchholzer ML; Werner C; Knoess W
Regul Toxicol Pharmacol; 2014 Mar; 68(2):193-200. PubMed ID: 24384395
[TBL] [Abstract][Full Text] [Related]
11. Legal requirements for the quality of herbal substances and herbal preparations for the manufacturing of herbal medicinal products in the European union.
Vlietinck A; Pieters L; Apers S
Planta Med; 2009 Jun; 75(7):683-8. PubMed ID: 19204891
[TBL] [Abstract][Full Text] [Related]
12. Granting marketing authorisation for medicines in South East European countries: the point of view of the authority.
Tomić S; Sucić AF; Martinac AI
Regul Toxicol Pharmacol; 2010; 57(2-3):325-32. PubMed ID: 20385190
[TBL] [Abstract][Full Text] [Related]
13. Evolution of European Union legislation of herbal medicinal products and its transposition to national legislation in 1965-2007: case Finland.
Koski SM; Laitinen-Parkkonen P; Airaksinen M
Int J Health Plann Manage; 2015; 30(3):260-75. PubMed ID: 24375722
[TBL] [Abstract][Full Text] [Related]
14. [Microbiological and biological methods of the European Pharmacopoeia. Relevant for each medicinal product].
Norwig J
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1158-68. PubMed ID: 25200487
[TBL] [Abstract][Full Text] [Related]
15. Regulation of immunological veterinary medicinal products in the European Union.
Brunko P
Rev Sci Tech; 1995 Dec; 14(4):1133-41. PubMed ID: 8639951
[TBL] [Abstract][Full Text] [Related]
16. Non-European traditional herbal medicines in Europe: a community herbal monograph perspective.
Qu L; Zou W; Zhou Z; Zhang T; Greef J; Wang M
J Ethnopharmacol; 2014 Oct; 156():107-14. PubMed ID: 25169214
[TBL] [Abstract][Full Text] [Related]
17. Regulation of medicinal plants for public health--European community monographs on herbal substances.
Knöss W; Chinou I
Planta Med; 2012 Aug; 78(12):1311-6. PubMed ID: 22618374
[TBL] [Abstract][Full Text] [Related]
18. New European commission regulation on variations to the terms of marketing authorization for medicinal products and its impact on Croatian legislation.
Martinac AI; Tomić S; Simicić M
Arh Hig Rada Toksikol; 2010 Sep; 61(3):311-22. PubMed ID: 20860972
[TBL] [Abstract][Full Text] [Related]
19. Requirements on efficacy of herbal medicinal products.
Claeson P
J Ethnopharmacol; 2014 Dec; 158 Pt B():463-6. PubMed ID: 25043782
[TBL] [Abstract][Full Text] [Related]
20. Marketing authorization of veterinary medicinal products in Poland.
Sztabińska-Koncka H; Lewicki J
Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 1):129-33. PubMed ID: 9339489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
